学歴・職歴

獲得科研費

その他獲得外部資金

1. Ohfuji S, Fukushima W, Tanaka T, Habu D, Tamori A, Sakaguchi H, Takeda T, Kawada N, Seki S, Nishiguchi S, Shiomi S, Hirota Y. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study. Hepatol Res 2006; 36: 201-8.
2. Ohfuji S, Fukushima W, Tanaka T, Habu D, Takeda T, Tamori A, Sakaguchi H, Seki S, Kawada N, Nishiguchi S, Shiomi S, Hirota Y. Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C? Hepatol Res. 2008; 38: 860-8.
3. Ohfuji S, Miyake Y, Arakawa M, Tanaka K, Sasaki S. Sibship size and prevalence of allergic disorders in Japan: The Ryukyus Child Health Study. Pediatr Allergy Immunol. 2009; 20: 377-84.
4. Ohfuji S, Fukushima W, Deguchi M, Kawabata K, Yoshida H, Hatayama H, Maeda A, Hirota Y. Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine Among Pregnant Women: Lowered Antibody Response by Prior Seasonal Vaccination. J Infect Dis. 2011; 203: 1301-8.
5. Ohfuji S, Fukushima W, Tamori A, Maeda K, Maeda A, Hirota Y. Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C. Influenza Other Respir Viruses. 2013; 7: 456-65.
6. Ohfuji S, Fukushima W, Sasaki Y, Tamori A, Kurai O, Kioka K, Maeda K, Maeda A, Hirota Y. Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients. Liver Int. 2014; 34: 700-6.
7. Ohfuji S, Fukushima W, Watanabe K, Sasaki S, Yamagami H, Nagahori M, Watanabe M, Hirota Y; Japanese Case-Control Study Group for Ulcerative Colitis. Pre-illness isoflavone consumption and disease risk of ulcerative colitis: a multicenter case-control study in Japan. PLoS One. 2014; 9: e110270.
8. Ohfuji S, Okada K, Nakano T, Ito H, Hara M, Kuroki H, Hirota Y. Effectiveness of acellular pertussis vaccine in a routine immunization program: A multicenter, case-control study in Japan. Vaccine 2015; 33: 1027-32.
9. Ohfuji S, Jingushi S, Kondo K, Sofue M, Itoman M, Matsumoto T, Hamada Y, Shindo H, Takatori Y, Yamada H, Yasunaga Y, Ito H, Mori S, Owan I, Fujii G, Ohashi H, Takahashi S, Hirota Y. Factors associated with diagnostic stage of hip osteoarthritis due to acetabular dysplasia among Japanese female patients: a cross-sectional study. BMC Musculoskelet Disord. 2016;17:320.
10. Ohfuji S, Ito K, Ishibashi M, Shindo S, Takasaki Y, Yokoyama T, Yokoyama T, Yamashita Y, Shibao K, Nakano T, Tsuru T, Irie S, Hirota Y. Immunogenicity study to investigate the interchangeability among three different types of polio vaccine: A cohort study in Japan. Medicine (Baltimore). 2017;96:e7073.
11. Ohfuji S, Kobayashi M, Ide Y, Egawa Y, Saito T, Kondo K, Ito K, Kase T, Maeda A, Fukushima W, Hirota Y. Key points in evaluating immunogenicity of pandemic influenza vaccines: A lesson from immunogenicity studies of influenza A(H1N1)pdm09 vaccine. Vaccine. 2017;35:5303-8.
12. Ohfuji S, Okada K, Nakano T, Ito H, Hara M, Kuroki H, Hirota Y. Control selection and confounding factors: a lesson from a Japanese case-control study to examine acellular pertussis vaccine effectiveness. Vaccine 2017;35:4801-5.
13. Ohfuji S, Deguchi M, Tachibana D, Koyama M, Takagi T, Yoshioka T, Urae A, Fukushima W, Hirota Y for the Osaka Pregnant Women Influenza Study Group. Estimating influenza disease burden among pregnant women: application of self-control method. Vaccine 2017;35:4811-6.
14. Ohfuji S, Deguchi M, Tachibana D, Koyama M, Takagi T, Yoshioka T, Urae A, Ito K, Kase T, Maeda A, Kondo K, Fukushima W, Hirota Y; Osaka Pregnant Women Influenza Study Group. Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study. J Infect Dis. 2018;217:878-886.